Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about SNY

Recent news which mentions SNY

< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
FDA Approves Regeneron/Sanofi's Blockbuster Dupixent For Smoker's Lung Disease
Tickers NEWS REGN SNY
Tags General FDA Benzinga
From Benzinga
Amgen's Rocatinlimab Has Commercial Potential Despite Competitive Landscape, Says Goldman Sachs
Tickers AMGN LLY NEWS SNY
Tags News Large Cap SNY
From Benzinga
Amgen's Rocatinlimab Data Beats Placebo In Atopic Dermatitis Trial, But Analyst Says Data Raises Concerns Amid Competitive Market
Tickers AMGN CGEM NEWS REGN
Tags Biotech CGEM Stories That Matter
From Benzinga
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
Tickers GS GSK HLN JNJ
Tags Briefs MS GS
From Benzinga
Sanofi Injects $27M In Neurology Drug Developer Ventyx Biosciences
Tickers NEWS SNY VTYX
Tags Market News Health Care Trading Ideas
From Benzinga
Sanofi's Sarclisa Secures FDA Approval For First-Line Multiple Myeloma, Marking Its Third US Approval
Tickers NEWS SNY
Tags General FDA Briefs
From Benzinga
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
Tickers CI CVS LLY NEWS
Tags SNY CVS Large Cap
From Benzinga
Sanofi's Tolebrutinib Delays Disability Progression In Patients With Multiple Sclerosis, Data Shows
Tickers NEWS SNY
Tags Stories That Matter Benzinga Biotech
From Benzinga
Novartis' Multiple Sclerosis Drug Data Shows Most Patients Remain With No Disability Progression For Up To Six Years
Tickers NEWS NVS SNY
Tags FDA General Market News
From Benzinga
Should You Buy Novavax Stock After This Regulatory Win?
Tickers BNTX JNJ MRNA NVAX
Tags PFE SNY Recent Press Releases
From Motley Fool
Sanofi, Regeneron Drug Dupixent Shows Successful Treatment Of Patients With Inflammatory Skin Disease
Tickers NEWS REGN SNY
Tags General Benzinga Biotech
From Benzinga
FDA Battles Backlog of Drug Factory Inspections Since COVID-19
Tickers BMRN BMY GSK LLY
Tags Health Care Regulations LLY
From Benzinga
Why Sanofi Stock Was Robustly Healthy Today
Tickers SNY
Tags SNY Market News Recent Press Releases
From Motley Fool
Sanofi Still Bets On Multiple Sclerosis Med Tolebrutinib Despite The Investigational Drug Fell Short In 2 Of 3 Phase 3 Trials
Tickers NEWS SNY
Tags Market News why it's moving Health Care
From Benzinga
European Stocks Little Moved On Labor Day, German DAX Mark Record Close, Natural Gas Futures Rise: What's Driving Markets Monday?
Tickers BBSRF BMWYY BX EADSY
Tags BBSRF PPRUY BMWYY
From Benzinga
Governments Suing Pharmacy Benefit Managers Over Insulin Prices Have Long Benefited From Their Rebates
Tickers LLY NEWS NVO SNY
Tags Market News News SNY
From Benzinga
Wall Street Predicts That This Stock Could Skyrocket by 65%: Time to Buy?
Tickers NVAX SNY
Tags SNY Market News Recent Press Releases
From Motley Fool
ARS Pharmaceuticals 'Neffy Uniquely Positioned With Potential To Change Allergy Treatment Paradigm For First Time In 40 years:' Analyst
Tickers NEWS SNY SPRY
Tags Trading Ideas Health Care Top Stories
From Benzinga
Florida Ruling Upholds GSK's Stance On Once Popular Heart Burn Drug Zantac Not Being Associated With Cancer Risk
Tickers GSK NEWS PFE SNY
Tags Briefs PFE Benzinga
From Benzinga
3 Biotech Stocks to Buy on the Dip: August 2024
Tickers LLY SNY VRTX
Tags Market News Uncategorized LLY
From InvestorPlace
FDA Approves ARS Pharma's Once Rejected Neffy Nasal Spray Alternative To EpiPen For Emergency Allergy Treatment
Tickers NEWS SNY SPRY
Tags Market News why it's moving Top Stories
From Benzinga
COVID-19 Vaccine Maker Novavax Trims Annual Outlook As Q2 Sales Take A Hit
Tickers NEWS NVAX SNY
Tags General NVAX Briefs
From Benzinga
Sanofi's Approved Blood Cancer Drug Sarclisa Shows Improved Progression-Free Survival In Patients Eligible For Transplant
Tickers NEWS SNY
Tags News Large Cap SNY
From Benzinga
Where Will Novavax Be in 5 Years?
Tickers MRNA NVAX SNY
Tags SNY NVAX Recent Press Releases
From Motley Fool
Regeneron Pharmaceuticals' Q2 Earnings Exceed Estimates, Driven By Its Top-Selling Eczema And Eye Drugs
Tickers NEWS REGN SNY
Tags General Benzinga Stories That Matter
From Benzinga
JPMorgan Just Cut Its Price Target on These 3 Stocks: July 31, 2024
Tickers JPM MCD NVAX SNY
Tags NYSE:JPM,NYSE:MCD,NASDAQ:NVAX,NASDAQ:ULCC,NASDAQ:SNY JPM MCD
From InvestorPlace
JPMorgan Just Issued a Warning on Novavax (NVAX) Stock
Tickers NVAX SNY
Tags Today's Market SNY NASDAQ:NVAX,NASDAQ:SNY
From InvestorPlace
Sanofi (SNY) Q2 2024 Earnings Call Transcript
Tickers SNY
Tags Recent Press Releases Market News SNY
From Motley Fool
Stocks Rebound As US Economy Flexes Muscles, Small Caps Rally, Gold Falls: What's Driving Markets Thursday?
Tickers AAL ABBV AZN BJRI
Tags BJRI VRSN F
From Benzinga
Sanofi Raises 2024 Profit Outlook On Strong Q2 Earnings, Blockbuster Drug Dupixent Sees Strong Demand
Tickers AZN NEWS REGN SNY
Tags Briefs REGN Stories That Matter
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.